Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Friedreich Ataxia
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,337,027 | Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Friedreich Ataxia Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp) In force · Low confidence UsedRemaining | Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp) | In force | Low confidence | ||
| Application 16/411,997 | Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp) Abandoned Abandoned Apr 7, 2021 | Institut National de la Santé et de la Recherche Médicale (Inserm), Université Paris-Sud XI and Assistance Publique - Hôpitaux de Paris (Aphp) | Abandoned | Abandoned Apr 7, 2021 | ||
| Application 14/764,065 | Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de Paris Abandoned Abandoned Apr 1, 2018 | Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de Paris | Abandoned | Abandoned Apr 1, 2018 | ||
| Application 15/916,907 | Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de Paris Abandoned Abandoned Dec 4, 2020 | Institut National de la Sante et de la Recherche Medicale (Inserm), Universite Paris-Sud XI and Assistance Publique-Hopitaux de Paris | Abandoned | Abandoned Dec 4, 2020 | ||
| Application 17/103,783 | Methods and Pharmaceutical Composition for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure Abandoned Abandoned Jun 24, 2024 | Université Paris-Saclay | Abandoned | Abandoned Jun 24, 2024 | ||
| Application 17/222,500 | Methods and Pharmaceutical Compositions for the Treatment and the Prevention of Cardiomyopathy Due to Energy Failure Abandoned Abandoned May 25, 2024 | Université Paris-Saclay | Abandoned | Abandoned May 25, 2024 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Université Paris-Sud.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.